Charts BIOSTAXPAR

Stocks

Market Closed - OTC Markets 13:27:45 2025-09-22 EDT			5-day change	1st Jan Change
0.000100 ^USD	-50.00%		-.--%	-

03-27	Callan Jmb Inc. Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2B/3 Advancement in A Collaboration Led by Difgen Pharmaceuticals, Aveva Drug Delivery Systems, Biostax Corp and Sgp Holdings	CI
03-25	DifGen Pharmaceuticals and Aveva Drug Delivery Systems Form Strategic Platform Collaboration with Biostax Corp D/B/A Attune Biotech, SGP Holdings, and Callan JMB	CI

ProRealTime Chart